Entity Details

Primary name RHG31_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionQ2M1Z3
EntryNameRHG31_HUMAN
FullNameRho GTPase-activating protein 31
TaxID9606
Evidenceevidence at protein level
Length1444
SequenceStatuscomplete
DateCreated2008-02-26
DateModified2021-06-02

Ontological Relatives

GenesARHGAP31

GO terms

Show/Hide Table
GOName
GO:0005096 GTPase activator activity
GO:0005829 cytosol
GO:0005925 focal adhesion
GO:0007264 small GTPase mediated signal transduction
GO:0017124 SH3 domain binding
GO:0030027 lamellipodium
GO:0051056 regulation of small GTPase mediated signal transduction

Subcellular Location

Show/Hide Table
Subcellular Location
Cell junction
Cell projection

Domains

Show/Hide Table
DomainNameCategoryType
IPR000198 Rho GTPase-activating protein domainDomainDomain
IPR008936 Rho GTPase activation proteinFamilyHomologous superfamily

Diseases

Show/Hide Table
Disease IDSourceNameDescription
100300 OMIMAdams-Oliver syndrome 1 (AOS1)A disorder characterized by the congenital absence of skin (aplasia cutis congenita) in combination with transverse limb defects. Aplasia cutis congenita can be located anywhere on the body, but in the vast majority of the cases, it is present on the posterior parietal region where it is often associated with an underlying defect of the parietal bones. Limb abnormalities are typically limb truncation defects affecting the distal phalanges or entire digits (true ectrodactyly). Only rarely, metatarsals/metacarpals or more proximal limb structures are also affected. Apart from transverse limb defects, syndactyly, most commonly of second and third toes, can also be observed. The clinical features are highly variable and can also include cardiovascular malformations, brain abnormalities and vascular defects such as cutis marmorata and dilated scalp veins. The disease is caused by variants affecting the gene represented in this entry.